Aquavit Files Investigation of New Drug for New Botulinum Toxin
Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.
Tag: Aquavit Pharmaceuticals
All
Popular
All
LatestSorry, No Posts Found
All
Latest
FDA Proposes Adding New Sunscreen Active Ingredient, Drawing Support From Dermatology Community
The agency is seeking public comment on a proposal to classify bemotrizinol as generally recognized as safe and effective for over-the-counter sunscreens.
